Stay up to date with the latest developments in urinary biomarkers for bladder cancer and UTUC. Explore educational articles, scientific reviews, expert commentaries, and clinical cases covering emerging evidence and evolving approaches to detection and surveillance.
Can urinary biomarkers help address some of the key limitations of cystoscopy and urine cytology in the surveillance of non-muscle-invasive bladder cancer (NMIBC)? Watch this expert presentation to...
Godelieve is a 77-year-old retired teacher. One year ago, she underwent TURBT of 1 small papillary tumour of 1 cm at the right bladder wall, which was detected during a cystoscopic examination for...
Improving detection of high-grade recurrences missed by WLC using a urinary biomarkerReviewed by Marek Babjuk Surveillance for non-muscle-invasive bladder cancer (NMIBC) relies on routine...
Peter, a 72-year-old retired engineer, was diagnosed with T1 high-grade (HG) non-muscle-invasive bladder cancer (NMIBC) 18 months ago. Following a successful transurethral resection of the bladder...
The DaBlaCa-15 trial paves the way for urinary biomarker integrationReviewed by Joost Boormans Non-muscle-invasive bladder cancer (NMIBC) demands diligent and often lifelong surveillance,...
Consider the same patient, but now with the following changes (marked in yellow): Henry, a 70-year-old former creative director in a chocolate company, was initially diagnosed with a solitary small...